Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Dental Caries

ClinicalTrials.gov lists 1,029 trials for Dental Caries or a narrower condition beneath it. Solventum US LLC has the most among industry and government lead sponsors, with 10.

MeSH D003731 Stomatognathic Diseases C07
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 37 Phase 1/2 Phase 1/2 8 Phase 2 Phase 2 42 Phase 2/3 Phase 2/3 14 Phase 3 Phase 3 47 Phase 4 Phase 4 44 Not applicable Not applicable 664 Observational Observational 173 Phase 1 Phase 1 37 Phase 1/2 Phase 1/2 8 Phase 2 Phase 2 42 Phase 2/3 Phase 2/3 14 Phase 3 Phase 3 47 Phase 4 Phase 4 44 Not applicable Not applicable 664 Observational Observational 173

Trials per phase (log scale)

996 of the 1,029 trials are tagged with Dental Caries itself; the rest are tagged with a narrower condition beneath it.

Get the Dental Caries report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Dental Caries trials start? (31)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 4 trials are registered to start in 2027 or later, and not listed here.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 91

1992: 1 trials (Observational 1) 1996: 1 trials (Phase 3 1) 1997: 1 trials (Phase 3 1) 1998: 2 trials (Observational 1, Phase 3 1) 2000: 1 trials (Not applicable 1) 2001: 2 trials (Not applicable 1, Phase 2 1) 2002: 1 trials (Phase 3 1) 2003: 7 trials (Phase 3 6, Phase 2 1) 2004: 7 trials (Observational 1, Not applicable 3, Phase 4 1, Phase 3 1, Phase 1 1) 2005: 5 trials (Not applicable 4, Phase 1 1) 2006: 10 trials (Observational 4, Not applicable 1, Phase 4 1, Phase 3 2, Phase 2 1, Phase 1 1) 2007: 16 trials (Observational 4, Not applicable 6, Phase 4 1, Phase 3 2, Phase 2/3 1, Phase 1/2 1, Phase 1 1) 2008: 22 trials (Observational 7, Not applicable 6, Phase 4 3, Phase 3 1, Phase 2/3 2, Phase 2 2, Phase 1 1) 2009: 20 trials (Observational 5, Not applicable 7, Phase 4 6, Phase 3 1, Phase 1 1) 2010: 18 trials (Observational 3, Not applicable 7, Phase 4 3, Phase 3 3, Phase 2 2) 2011: 25 trials (Observational 2, Not applicable 13, Phase 4 1, Phase 3 2, Phase 2/3 1, Phase 2 2, Phase 1 4) 2012: 37 trials (Observational 4, Not applicable 21, Phase 4 2, Phase 3 3, Phase 2/3 4, Phase 2 1, Phase 1 2) 2013: 28 trials (Observational 3, Not applicable 17, Phase 4 3, Phase 3 1, Phase 1/2 1, Phase 1 3) 2014: 41 trials (Observational 1, Not applicable 29, Phase 4 2, Phase 2/3 1, Phase 2 4, Phase 1/2 1, Phase 1 3) 2015: 52 trials (Observational 5, Not applicable 33, Phase 4 5, Phase 2/3 2, Phase 2 4, Phase 1/2 1, Phase 1 2) 2016: 47 trials (Observational 10, Not applicable 28, Phase 4 2, Phase 3 2, Phase 2 2, Phase 1/2 2, Phase 1 1) 2017: 67 trials (Observational 7, Not applicable 47, Phase 4 2, Phase 3 3, Phase 2 7, Phase 1 1) 2018: 59 trials (Observational 10, Not applicable 41, Phase 3 4, Phase 2/3 1, Phase 2 2, Phase 1 1) 2019: 69 trials (Observational 12, Not applicable 47, Phase 4 1, Phase 3 2, Phase 2 4, Phase 1/2 1, Phase 1 2) 2020: 45 trials (Observational 9, Not applicable 26, Phase 4 3, Phase 3 1, Phase 2/3 1, Phase 2 5) 2021: 67 trials (Observational 8, Not applicable 51, Phase 4 1, Phase 2 1, Phase 1 6) 2022: 61 trials (Observational 12, Not applicable 44, Phase 4 1, Phase 3 2, Phase 1 2) 2023: 68 trials (Observational 12, Not applicable 49, Phase 4 4, Phase 3 1, Phase 1 2) 2024: 91 trials (Observational 21, Not applicable 68, Phase 3 1, Phase 1/2 1) 2025: 89 trials (Observational 19, Not applicable 62, Phase 4 1, Phase 3 2, Phase 2/3 1, Phase 2 2, Phase 1 2)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 63
2025 89
2024 91
2023 68
2022 61
2021 67
2020 45
2019 69
2018 59
2017 67

Forecast of the full-year count, planned starts included, not rows of this table: about 81 trials starting in 2026 and about 83 in 2027, the average of the 24 months through September, counted as registered and carried forward, with about 0.7 times the starts already registered for the rest of 2026 added. The rows of this table count trials registered so far with a start date in the year, planned starts included; the forecast looks ahead to the count for the whole year, so it is not the same measure. In backtests on conditions of this size, forecasts made part-way through the year were typically off by about 15 percent and ran about 1 percent high against the count later registered; forecasts made before the year began were off by about 26 percent and ran about 20 percent low against the count later registered. The part-way figures are from forecasts that used a multiple fitted only on earlier years. These figures rest on a few years of history (target years from 2018 to 2025, varying by figure), place each condition as it is mapped today rather than as it was then, and score against a count for the newest year that was still being revised. Only condition series were scored.

Prediction, not a registry value: median of 36 months from start to primary completion across 62 trials still running at the 2026-10-09 snapshot; registered median of 13 months across 648 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Dental Caries trials in? (8)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 37
Phase 1/2 8
Phase 2 42
Phase 2/3 14
Phase 3 47
Phase 4 44
Not applicable 664
Observational 173

How many Dental Caries trials are recruiting? (9)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 83
Recruiting 61
Enrolling by invitation 14
Active, not recruiting 36
Completed 593

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Dental Caries trials? (2)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Solventum US LLC 10
Dental Practice-Based Research Network 9

Which drugs are being tested for Dental Caries? (2)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Potassium Nitrate Toothpaste 7
Xylitol 6

Interventions as named in the registry (13)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Silver diamine Fluoride 38% 33
Fluoride Varnish 27
Fluoride 16
Fluoride Toothpaste 9
Atraumatic Restorative Treatment 7

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Dental Caries trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Death 27 4
Pneumonia 6 2
Appendicitis 4 2
Kidney infection 3 1
Rotator Cuff Injury 3 1

Which publications cover Dental Caries? (1,890)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Sub-conditions in MeSH (1)

MeSH descendants one level down with at least one trial, most trials first.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: prevalence and rare-disease identity.

Browse all condition evidence pages